In June 2008, repaglinide and metformin HCl (PrandiMet®) was approved by the FDA. This is the first and only FDC tablet of repaglinide and metformin for the treatment of T2DM.
Expert Rev Endocrinol Metab. 2010;5(3):331-342. © 2010 Expert Reviews Ltd.
Cite this: Combination Therapy for Patients with Type 2 Diabetes: Repaglinide in Combination with Metformin - Medscape - May 01, 2010.